🚀 VC round data is live in beta, check it out!
Largest Public Companies in the UK
Benchmark revenue and EBITDA valuation multiples for public comps like
AstraZeneca, HSBC, Shell, Rio Tinto UK and ARM.
 | $202 | +41% | $314B | $337B | 5.6x | 16.1x | ||
| $17 | +51% | $288B | $246B | 3.4x | — | ||
| $47 | +43% | $262B | $308B | 1.1x | 5.3x | ||
| $94 | +58% | $153B | $169B | 2.9x | 6.7x | ||
| $124 | +9% | $132B | $129B | 26.2x | 55.8x | ||
| $16 | +56% | $131B | $128B | 4.6x | 22.0x | ||
| $58 | +34% | $126B | $167B | 4.7x | 9.9x | ||
| $8 | +67% | $120B | $161B | 0.9x | 4.3x | ||
| $55 | -23% | $120B | $146B | 2.4x | 10.8x | ||
| $28 | +43% | $113B | $132B | 3.0x | 8.7x | ||
| $18 | +28% | $92B | $147B | 5.7x | 13.6x | ||
| $30 | +30% | $88B | $96B | 2.4x | 16.4x | ||
| $1 | +32% | $76B | $106B | 4.1x | — | ||
| $5 | +36% | $74B | $166B | 4.1x | — | ||
| $8 | +19% | $60B | $49B | 2.1x | — | ||
| $33 | -39% | $60B | $69B | 5.2x | 13.0x | ||
| $118 | -24% | $58B | $70B | 5.7x | 11.3x | ||
| $23 | +59% | $52B | $72B | 3.4x | — | ||
| $29 | -13% | $50B | $56B | 1.2x | 11.5x | ||
| $44 | +42% | $47B | $56B | 2.9x | 8.2x | ||
| $46 | +109% | $45B | $47B | 5.3x | 8.6x | ||
| $68 | +2% | $44B | $53B | 2.9x | 9.8x | ||
| $5 | -3% | $44B | $53B | 3.6x | 13.8x | ||
| PE & VC+1 | $43 | -25% | $43B | $45B | 5.2x | 5.7x | |
| $36 | +57% | $43B | $56B | 4.2x | 13.0x | ||
| $92 | +2% | $41B | $52B | 2.1x | 11.9x | ||
| $6 | +30% | $41B | $55B | 0.6x | 8.4x | ||
| $18 | -34% | $41B | $62B | 3.1x | 9.5x | ||
| $14 | +35% | $36B | $37B | 8.2x | 10.6x | ||
| $26 | +52% | $35B | $61B | 2.2x | 8.4x | ||
| $2 | +55% | $35B | $79B | 1.7x | 5.9x | ||
| $41 | -1% | $32B | $43B | 3.2x | 7.4x | ||
| $34 | -31% | $31B | $36B | 4.3x | 12.0x | ||
| $72 | +35% | $30B | $40B | 3.7x | 8.0x | ||
| $3 | +23% | $28B | $57B | 2.2x | 5.2x | ||
| $9 | +20% | $27B | $9B | 0.2x | 3.0x | ||
| $5 | +39% | $22B | $29B | 0.7x | 3.2x | ||
| $8 | +26% | $21B | $23B | 40.1x | 145.0x | ||
| $54 | +48% | $21B | $21B | 6.3x | 25.2x | ||
| $175 | +6% | $20B | $22B | 2.4x | 10.7x | ||
| $28 | +142% | $20B | $16B | 1460.9x | (13.4x) | ||
| $134 | +26% | $20B | $24B | 4.5x | 17.4x | ||
| $120 | +119% | $19B | $21B | 5.1x | 22.7x | ||
| $3 | +7% | $19B | $3B | 0.2x | 1.2x | ||
| $40 | -13% | $18B | $33B | 1.6x | 9.9x | ||
| $25 | -10% | $18B | $21B | 0.8x | 6.1x | ||
| $5 | +107% | $17B | $23B | 3.6x | 7.2x | ||
| $16 | +30% | $17B | $19B | — | — | ||
| $68 | +154% | $16B | $17B | 3.7x | 6.4x | ||
| $6 | +37% | $16B | $20B | 2.8x | 12.8x | ||
| $11 | +20% | $15B | $21B | 23.6x | 25.5x | ||
| $16 | +13% | $14B | $16B | 2.6x | 10.0x | ||
| $11 | +9% | $13B | $18B | 3.2x | 10.3x | ||
| $43 | +16% | $13B | $25B | 6.7x | 14.0x | ||
| $18 | +22% | $13B | $25B | 7.3x | 12.1x | ||
| $8 | +76% | $12B | $5B | 1.5x | 4.4x | ||
| $39 | -10% | $12B | $13B | 1.7x | 10.3x | ||
| $3 | +19% | $12B | $10B | 0.3x | 5.3x | ||
| $11 | -12% | $11B | ($8B) | (3.8x) | (11.9x) | ||
| $10 | -- | $11B | $17B | 3.7x | 8.2x | ||
| $35 | +39% | $11B | $11B | 3.6x | 15.0x | ||
| $9 | -- | $10B | $15B | 1.9x | 25.9x | ||
| $11 | -33% | $10B | $12B | 3.4x | 12.9x | ||
| $5 | +27% | $10B | $17B | 0.4x | 5.7x | ||
| $17 | +42% | $10B | $9B | 1.5x | 8.0x | ||
| $74 | +39% | $10B | $10B | 4.9x | 18.8x | ||
| $38 | +27% | $10B | $12B | 3.3x | 13.9x | ||
| $4 | +50% | $10B | $12B | 6.7x | — | ||
| $56 | +17% | $10B | $13B | — | — | ||
| $30 | -6% | $10B | $13B | 0.8x | 8.1x | ||
| $5 | -10% | $9B | $13B | 0.6x | 6.9x | ||
| $37 | +58% | $9B | $10B | 3.3x | 13.9x | ||
| $17 | +39% | $9B | $1B | 1.3x | 2.3x | ||
| $7 | +21% | $9B | $11B | 2.2x | 10.2x | ||
| $17 | +57% | $8B | $9B | 1.3x | 12.4x | ||
| $13 | -17% | $8B | $10B | 2.0x | 9.0x | ||
| $233 | +13% | $8B | $8B | 8.9x | 19.7x | ||
| $16 | +17% | $8B | $8B | — | — | ||
| $49 | -20% | $8B | $9B | 2.0x | 9.0x | ||
| $7 | +71% | $7B | $7B | — | — | ||
| $10 | +182% | $7B | $6B | 4.8x | 8.5x | ||
| $91 | +16% | $7B | $8B | 3.3x | 13.9x | ||
| $5 | -25% | $7B | $6B | 0.8x | 8.1x | ||
| $3 | +9% | $7B | $10B | 16.7x | 17.7x | ||
| $3 | -6% | $6B | $8B | 3.1x | 11.8x | ||
| $22 | -14% | $6B | $6B | 4.7x | 7.9x | ||
| $4 | -3% | $6B | $9B | 0.5x | 4.9x | ||
| $12 | +12% | $6B | $7B | 2.0x | 9.5x | ||
| $19 | +11% | $6B | $6B | 1.2x | 9.0x | ||
| $142 | +78% | $6B | $11B | 6.5x | — | ||
| $16 | +7% | $6B | $7B | — | — | ||
| $18 | +24% | $6B | $5B | 3.5x | 7.3x | ||
| $10 | +69% | $6B | $5B | 7.1x | 11.2x | ||
| $68 | +4% | $6B | $7B | 0.3x | 6.2x | ||
| $4 | +75% | $6B | $10B | 1.0x | 1.4x | ||
| $34 | -3% | $6B | $12B | 3.1x | 8.6x | ||
| $39 | 0% | $5B | $6B | 2.7x | 11.2x | ||
| $23 | +151% | $5B | $11B | 2.5x | 5.2x | ||
| $3 | +49% | $5B | $6B | 3.5x | 13.8x | ||
| $6 | -44% | $5B | $5B | 6.3x | 9.3x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of last 12 months. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.